Cell cycle arrest and cell survival induce reverse trends of cardiolipin remodeling

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Chao, Yu Jen ^a   Chang, Wan Hsin ^a   Ting, Hsiu Chi ^a   Chao, Wei Ting ^a   Hsu, Yuan Hao Howard ^a  

^a TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE PROGRESSION; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DNA REPLICATION; FIBROSARCOMA CELL; FIBROSARCOMA CELL LINE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; LIPID COMPOSITION; MASS SPECTROMETRY; MITOCHONDRION; MITOSIS; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; S PHASE CELL CYCLE CHECKPOINT; STATIC ELECTRICITY; CELL CYCLE; LIQUID CHROMATOGRAPHY; PHYSIOLOGY; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE;

CARDIOLIPINS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATOGRAPHY, LIQUID; FLOW CYTOMETRY; HUMANS; TANDEM MASS SPECTROMETRY;

EID: 84913538886     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113680     Document Type: Article

References (55)

1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257.
2. Proskuryakov SY, Konoplyannikov AG, Gabai VL. Necrosis: a specific form of programmed cell death? Exp Cell Res. 2003;283:1-16.
3. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009;9:153-166.
4. Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 2003;36:131-149.
5. Temple S, Raff MC. Clonal analysis of oligodendrocyte development in culture: evidence for a developmental clock that counts cell divisions. Cell. 1986;44:773-779.
6. Jackowski S. Cell cycle regulation of membrane phospholipid metabolism. J Biol Chem. 1996;271:20219-20222.
7. Hauff K, Linda D, Hatch GM. Mechanism of the elevation in cardiolipin during HeLa cell entry into the S-phase of the human cell cycle. Biochem J. 2009;417:573-582.
8. Hooks SB, Cummings BS. Role of Ca2+-independent phospholipase A2 in cell growth and signaling. Biochem Pharmacol. 2008;76:1059-1067.
9. Dennis EA, Cao J, Hsu YH, Magrioti V, Kokotos G. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev. 2011;111:6130-6185.
10. Schlame M. Cardiolipin remodeling and the function of tafazzin. Biochim Biophys Acta. 2013;1831:582-588.
11. Jackowski S. Coordination of membrane phospholipid synthesis with the cell cycle. J Biol Chem. 1994;269:3858-3867.
12. Xiong W, Jiao Y, Huang W, Ma M, Yu M, et al. Regulation of the cell cycle via mitochondrial gene expression and energy metabolism in HeLa cells. Acta Biochim Biophys Sin (Shanghai). 2012;44:347-358.
13. Lee S, Kim S, Sun X, Lee JH, Cho H. Cell cycle-dependent mitochondrial biogenesis and dynamics in mammalian cells. Biochem Biophys Res Commun. 2007;357:111-117.
14. Pangborn MC. The composition of cardiolipin. J Biol Chem. 1947;168:351-361.
15. Hirschberg CB, Kennedy EP. Mechanism of the enzymatic synthesis of cardiolipin in Escherichia coli. Proc Natl Acad Sci U S A. 1972;69:648-651.
16. Hostetler KY, van den Bosch H, van Deenen LL. The mechanism of cardiolipin biosynthesis in liver mitochondria. Biochim Biophys Acta. 1972;260:507-513.
17. Ascenzi P, Polticelli F, Marino M, Santucci R, Coletta M. Cardiolipin drives cytochrome c proapoptotic and antiapoptotic actions. IUBMB Life. 2011;63:160-165.
18. Claypool SM. Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function. Biochim Biophys Acta. 2009;1788:2059-2068.
19. Sparagna GC, Lesnefsky EJ. Cardiolipin remodeling in the heart. J Cardiovasc Pharmacol. 2009;53:290-301.
20. Gomez B, Jr., Robinson NC. Phospholipase digestion of bound cardiolipin reversibly inactivates bovine cytochrome bc1. Biochemistry. 1999;38:9031-9038.
21. Eble KS, Coleman WB, Hantgan RR, Cunningham CC. Tightly associated cardiolipin in the bovine heart mitochondrial ATP synthase as analyzed by 31P nuclear magnetic resonance spectroscopy. J Biol Chem. 1990;265:19434-19440.
22. Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Federici A, et al. Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: involvement of reactive oxygen species and cardiolipin. Circ Res. 2004;94:53-59.
23. Lesnefsky EJ, Slabe TJ, Stoll MS, Minkler PE, Hoppel CL. Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol. 2001;280:H2770-2778.
24. Paradies G, Petrosillo G, Ruggiero FM. Cardiolipin-dependent decrease of cytochrome c oxidase activity in heart mitochondria from hypothyroid rats. Biochim Biophys Acta. 1997;1319:5-8.
25. Monteiro JP, Oliveira PJ, Jurado AS. Mitochondrial membrane lipid remodeling in pathophysiology: a new target for diet and therapeutic interventions. Prog Lipid Res. 2013;52:513-528.
26. Xu Y, Sutachan JJ, Plesken H, Kelley RI, Schlame M. Characterization of lymphoblast mitochondria from patients with Barth syndrome. Lab Invest. 2005;85:823-830.
27. Gonzalvez F, D'Aurelio M, Boutant M, Moustapha A, Puech JP, et al. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation. Biochim Biophys Acta. 2013;1832:1194-1206.
28. Kalanxhi E, Wallace CJ. Cytochrome c impaled: investigation of the extended lipid anchorage of a soluble protein to mitochondrial membrane models. Biochem J. 2007;407:179-187.
29. Ott M, Zhivotovsky B, Orrenius S. Role of cardiolipin in cytochrome c release from mitochondria. Cell Death Differ. 2007;14:1243-1247.
30. Belikova NA, Vladimirov YA, Osipov AN, Kapralov AA, Tyurin VA, et al. Peroxidase activity and structural transitions of cytochrome c bound to cardiolipin-containing membranes. Biochemistry. 2006;45:4998-5009.
31. Abe M, Niibayashi R, Koubori S, Moriyama I, Miyoshi H. Molecular mechanisms for the induction of peroxidase activity of the cytochrome c-cardiolipin complex. Biochemistry. 2011;50:8383-8391.
32. Sedlak E, Robinson NC. Phospholipase A(2) digestion of cardiolipin bound to bovine cytochrome c oxidase alters both activity and quaternary structure. Biochemistry. 1999;38:14966-14972.
33. Dieude M, Striegl H, Tyznik AJ, Wang J, Behar SM, et al. Cardiolipin binds to CD1d and stimulates CD1d-restricted gammadelta T cells in the normal murine repertoire. J Immunol. 2011;186:4771-4781.
34. Yankovskaya V, Horsefield R, Tornroth S, Luna-Chavez C, Miyoshi H, et al. Architecture of succinate dehydrogenase and reactive oxygen species generation. Science. 2003;299:700-704.
35. Yang J, Kulkarni K, Manolaridis I, Zhang Z, Dodd RB, et al. Mechanism of isoprenylcysteine carboxyl methylation from the crystal structure of the integral membrane methyltransferase ICMT. Mol Cell. 2011;44:997-1004.
36. Shintre CA, Pike AC, Li Q, Kim JI, Barr AJ, et al. Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound states. Proc Natl Acad Sci U S A. 2013;110:9710-9715.
37. Schlame M, Ren M, Xu Y, Greenberg ML, Haller I. Molecular symmetry in mitochondrial cardiolipins. Chem Phys Lipids. 2005;138:38-49.
38. Kraffe E, Grall J, Le Duff M, Soudant P, Marty Y. A striking parallel between cardiolipin fatty acid composition and phylogenetic belonging in marine bivalves: a possible adaptative evolution? Lipids. 2008;43:961-970.
39. Kiebish MA, Han X, Cheng H, Chuang JH, Seyfried TN. Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J Lipid Res. 2008;49:2545-2556.
40. Yoshinaga MY, Wormer L, Elvert M, Hinrichs KU. Novel cardiolipins from uncultured methanemetabolizing archaea. Archaea. 2012;2012:832097.
41. Hsu YH, Dumlao DS, Cao J, Dennis EA. Assessing phospholipase A2 activity toward cardiolipin by mass spectrometry. PLoS One. 2013;8:e59267.
42. Martinez-Diez M, Santamaria G, Ortega AD, Cuezva JM. Biogenesis and dynamics of mitochondria during the cell cycle: significance of 3'UTRs. PLoS One. 2006;1:e107.
43. Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science. 2012;337:1062-1065.
44. Osman C, Voelker DR, Langer T. Making heads or tails of phospholipids in mitochondria. J Cell Biol. 2011;192:7-16.
45. Antico Arciuch VG, Elguero ME, Poderoso JJ, Carreras MC. Mitochondrial regulation of cell cycle and proliferation. Antioxid Redox Signal. 2012;16:1150-1180.
46. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-917.
47. Bird SS, Marur VR, Sniatynski MJ, Greenberg HK, Kristal BS. Lipidomics profiling by high-resolution LC-MS and high-energy collisional dissociation fragmentation: focus on characterization of mitochondrial cardiolipins and monolysocardiolipins. Anal Chem. 2011;83:940-949.
48. Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007;7:834-846.
49. Dumas JF, Peyta L, Couet C, Servais S. Implication of liver cardiolipins in mitochondrial energy metabolism disorder in cancer cachexia. Biochimie. 2013;95:27-32.
50. Schug ZT, Frezza C, Galbraith LC, Gottlieb E. The music of lipids: how lipid composition orchestrates cellular behaviour. Acta Oncol. 2012;51:301-310.
51. Tyurina YY, Domingues RM, Tyurin VA, Maciel E, Domingues P, et al. Characterization of cardiolipins and their oxidation products by LC-MS analysis. Chem Phys Lipids. 2014;179:3-10.
52. Baile MG, Lu YW, Claypool SM. The topology and regulation of cardiolipin biosynthesis and remodeling in yeast. Chem Phys Lipids. 2014;179:25-31.
53. Xu Y, Schlame M. The turnover of glycerol and acyl moieties of cardiolipin. Chem Phys Lipids. 2014;179:17-24.
54. Hardie DG. New roles for the LKB1 - >AMPK pathway. Curr Opin Cell Biol. 2005;17:167-173.
55. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell. 2005;18:283-293.